Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
strain that causes acute respiratory illnesses known as coronavirus disease 2019 (COVID …

Abstract Coronavirus disease 2019 (COVID-19) represents an unmet clinical need, due to a
high mortality rate, rapid mutation rate in the virus, increased chances of reinfection, lack of …

COVID-19 is a major public health problem, with still questionable specific cure. Favipiravir
is a COVID-19 antiviral that is potentially a therapy for COVID-19. This study aimed to …

Diawal tahun 2020, dunia digemparkan dengan merebaknya virus baru yaitu coronavirus
jenis baru (SARS-CoV-2) dan penyakitnya disebut Coronavirus disease 2019 (COVID-19) …

The global pandemic COVID-19 in 2019 has led to a continued search for promising
potential molecules to combat human viral diseases. An in silico strategy was attempted to …

Cytokine storm in COVID-19 infection is an excessive immune response to external stimuli
where the pathogenesis is complex. The disease progresses rapidly and the mortality is …

Coronavirus 19 atau yang dikenal dengan COVID-19 adalah suatu penyakit yang
disebabkan oleh virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

The COVID-19 pandemic has caused substantial morbidity and mortality worldwide. Older
patients, male gender and those with preexisting comorbidities such as chronic kidney …

SARS-CoV-2 main protease is a potential target for the development of AntiCOVID-19.
Several chalcones have inhibitory activity against 3CL pro SARS-CoV and 3CL pro MERS …

Since the COVID-19 pandemic in Indonesia, pharmacological therapy for COVID-19 cases
to date arecurrently based on clinician's assessments of drugs, or what drug …